This mechanism was found to mediate chemoresistance to cisplatin in gastric cancer as high pre-therapeutic serums levels of IL-8 (446.71 ± 111.07 pg/ml) predicted poor response to platinum-based chemotherapy (93). This evidence concerns the gene CXCL8 and gastric cancer.